Brief: Panbela Announces Publication Of Preclinical Data Titled Expanded Potential Of The Polyamine Analogue SBP-101 (Diethyl Dihydroxyhomospermine) As A Modulator Of Polyamine Metabolism And Cancer Therapeutic
28/06/2022 13:10
June 28 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA ANNOUNCES PUBLICATION OF PRECLINICAL DATA TITLED:
EXPANDED POTENTIAL OF THE POLYAMINE ANALOGUE SBP-101 (DIETHYL
DIHYDROXYHOMOSPERMINE) AS A MODULATOR OF POLYAMINE METABOLISM
AND CANCER THERAPEUTIC
Source text for Eikon: ID:nGNXbn79Yb
Further company coverage: PBLA.O
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants